S1449 Long-Term Endoscopic and Histological Outcomes of Mirikizumab in Patients With Moderately to Severely Active Ulcerative Colitis With up to 3 Years of Treatment
Year: 2024
Type: conference-abstract
Institutions: Icahn School of Medicine at Mount Sinai, Kitasato Institute Hospital, Kitasato University, Eli Lilly (United States), Eli Lilly (Portugal), Inserm, McGill University Health Centre, Centre Hospitalier Régional et Universitaire de Nancy, Nutrition-Génétique et Exposition aux Risques Environnementaux, University of Oxford, Oxford University Hospitals NHS Trust, Universidade do Porto
Language: English
Topic: Inflammatory Bowel Disease
Subfield: Gastroenterology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4403722039